Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The vesicular exocytosis machinery is a complex network of proteins and molecular complexes that mediate the fusion of intracellular vesicles with target membranes, releasing their contents. Key components include SNARE proteins (synaptobrevin, syntaxin, SNAP-25), accessory proteins (synaptotagmin, complexin, Munc18/nSec1, Munc13, Rab3 GTPase, exocyst complexes), and disassembly factors (NSF, SNAPs). This machinery is crucial for diverse cellular processes, including neurotransmitter release, hormone secretion, and immune cell degranulation. Dysregulation of exocytosis can contribute to various diseases, and it is targeted by several therapeutic interventions. In bacteria, outer-membrane vesicle-mediated exocytosis performs analogous functions.
Variable depending on the specific drug and target within the machinery. Examples include SNARE cleavage by toxins, modulation of calcium influx, and interference with vesicle docking/priming.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Vesicular Exocytosis Machinery (N/A).